PMID- 17384445 OWN - NLM STAT- MEDLINE DCOM- 20070605 LR - 20190819 IS - 1346-9843 (Print) IS - 1346-9843 (Linking) VI - 71 IP - 4 DP - 2007 Apr TI - Upregulation of KCNE1 induces QT interval prolongation in patients with chronic heart failure. PG - 471-8 AB - BACKGROUND: Prolongation of the action potential duration (APD) is observed in ventricular myocytes isolated from the failing heart. The rapid component (I(Kr)) and the slow component (I(Ks)) of the delayed-rectifier potassium current (I(K)) are major determinants of the APD, but less information is available on the genomic modulation of I(K) in the remodeled human heart. The aim of the current study was to examine the relationship between I(K) transcripts and QT interval in surface electrocardiogram in patients with chronic heart failure (CHF). METHODS AND RESULTS: Total RNA was extracted from right ventricle endomyocardial biopsy samples in 21 CHF patients (age: 53+/-4 years, mean +/- SEM). The KCNH2 and KCNQ1 levels did not differ significantly between controls (New York Heart Association (NYHA) I, n=10) and CHF patients (NYHA II or III, n=11), whereas the KCNE1 level was significantly higher in CHF patients than in controls (relative mRNA levels normalized to GAPDH expression: 6.16+/-0.31 vs 7.70+/-0.46, p<0.05). The KCNE1/KCNQ1 ratio was higher in CHF patients than in controls (0.92+/-0.02 vs 1.06+/-0.05, p<0.05) and the KCNE1-KCNQ1 ratio was positively correlated with QT interval (r=0.70, p<0.05). Increasing the KCNE1 concentration caused a shift in activation voltage and slowed the activation kinetics of the KCNE1-KCNQ1 currents expressed in Xenopus oocytes. Prolongation of the APD and decrease in I(Ks) with increasing the amount of KCNE1 concentration were well predicted in a computer simulation. CONCLUSIONS: In mild-to-moderate CHF patients, the relative abundance of KCNE1 compared to KCNQ1 genes, at least in part, might contribute to the preferential prolongation of QT interval through reducing the net outward current during the plateau of the action potential. FAU - Watanabe, Eiichi AU - Watanabe E AD - Division of Cardiology, Department of Internal Medicine, Fujita Health University School of Medicine, Toyoake. FAU - Yasui, Kenji AU - Yasui K FAU - Kamiya, Kaichiro AU - Kamiya K FAU - Yamaguchi, Takahiro AU - Yamaguchi T FAU - Sakuma, Ichiro AU - Sakuma I FAU - Honjo, Haruo AU - Honjo H FAU - Ozaki, Yukio AU - Ozaki Y FAU - Morimoto, Shinichiro AU - Morimoto S FAU - Hishida, Hitoshi AU - Hishida H FAU - Kodama, Itsuo AU - Kodama I LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Japan TA - Circ J JT - Circulation journal : official journal of the Japanese Circulation Society JID - 101137683 RN - 0 (Delayed Rectifier Potassium Channels) RN - 0 (ERG1 Potassium Channel) RN - 0 (Ether-A-Go-Go Potassium Channels) RN - 0 (KCNE1 protein, human) RN - 0 (KCNH2 protein, human) RN - 0 (KCNQ1 Potassium Channel) RN - 0 (Potassium Channels, Voltage-Gated) RN - 0 (RNA, Messenger) SB - IM MH - Action Potentials/physiology MH - Adolescent MH - Adult MH - Aged MH - Animals MH - Cardiac Output, Low/genetics/*metabolism/physiopathology MH - Chronic Disease MH - Delayed Rectifier Potassium Channels/genetics/metabolism MH - ERG1 Potassium Channel MH - *Electrocardiography MH - Ether-A-Go-Go Potassium Channels/genetics/metabolism MH - Female MH - Heart Ventricles/metabolism MH - Humans MH - KCNQ1 Potassium Channel/genetics/metabolism MH - Long QT Syndrome/genetics/metabolism MH - Male MH - Middle Aged MH - Myocytes, Cardiac/metabolism/pathology MH - Oocytes/cytology/metabolism MH - Potassium Channels, Voltage-Gated/genetics/*metabolism MH - RNA, Messenger/genetics/metabolism MH - Up-Regulation/genetics/*physiology MH - Xenopus laevis EDAT- 2007/03/27 09:00 MHDA- 2007/06/06 09:00 CRDT- 2007/03/27 09:00 PHST- 2007/03/27 09:00 [pubmed] PHST- 2007/06/06 09:00 [medline] PHST- 2007/03/27 09:00 [entrez] AID - JST.JSTAGE/circj/71.471 [pii] AID - 10.1253/circj.71.471 [doi] PST - ppublish SO - Circ J. 2007 Apr;71(4):471-8. doi: 10.1253/circj.71.471.